City of Hope Medical Center - Recruiting 16 years or older. - Pharmacologic Reversal of Ventricular Remodeling in Childhood Cancer Survivors at Risk for Congestive Heart Failure (PREVENT-CHF): A Phase IIB Randomized Placebo-Controlled Trial.
Ikaria Holdings Inc. - Recruiting 18 years or older. - A Placebo Controlled , Multicenter, Randomized, Double Blind Trial to Evaluate the Safety and Effectiveness of IK-5001 for the Prevention of Remodeling of the Ventricle and Congestive Heart Failure After Acute Myocardial Infarction - Preservation I Trial.
Sodium Alginate and Calcium Gluconate; Saline Solution
Ageless Regenerative Institute - Recruiting 18 years to 80 years. - An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Cardiovascular Effects of Intramyocardial and Intravenous Implantation of Autologous Adipose-Derived Stem Cells in Non-Ischemic Congestive Heart Failure Patients.
Harvesting and Implantation of Adipose-Derived Stem Cells (ASCs)